EPAとDHA市場：供給源別、形態別、用途別、地域別

世界のEPAとDHA市場は、2025年には20億7,000万米ドルと推定され、2032年には33億2,000万米ドルに達すると予測され、2025～2032年にかけて7.0%のCAGR（複合年間成長率）で成長すると予測されています。

図.EPAとDHA市場の地域別シェア（%）（2025年）

EPAとDHAの世界市場は、消費者の健康意識の高まりと、これらの主要なオメガ3脂肪酸を含むサプリメントの採用拡大により、著しい成長を遂げています。EPAとDHAは海洋由来の多価不飽和脂肪酸で、脳や目の健康、心血管の健康に重要な役割を果たしています。高齢化社会の進展に伴う生活習慣病の蔓延が、EPAとDHAサプリメントの需要を押し上げています。様々な臨床研究によって、EPAとDHAが炎症を抑え、心臓病のリスクを低下させ、神経機能を向上させるという広範囲に及ぶ利点が実証されています。科学的根拠が高まるにつれ、サプリメントだけでなく食品からもこれらの必須脂肪酸を摂取する人が増えています。

市場力学

EPAとDHAの健康効果や慢性疾患の蔓延に関する消費者の意識の高まりが、EPAとDHAサプリメントの世界の売上を押し上げています。しかし、原料の調達コストが高いことが、市場参入者にとって大きな課題となっています。魚油の豊富な利用可能性とオメガ3脂肪酸の代替菜食主義者の出現は、市場拡大のための有利な機会を提示します。新たな用途への持続的な研究開発は、EPAとDHAの臨床用途と市場への働きかけを拡大する可能性があります。

本調査の主要特徴

本レポートでは、世界のEPAとDHA市場を詳細に分析し、2024年を基準年とした予測期間（2025～2032年）の市場規模（10億米ドル）と複合年間成長率（CAGR%）を提供しています。

また、さまざまなセグメントにわたる潜在的な収益機会を解明し、この市場の魅力的な投資提案のマトリックスについて説明しています。

また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域による展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。

企業ハイライト、製品ポートフォリオ、主要なハイライト、財務実績、戦略などのパラメータに基づいて、世界のEPAとDHA市場の主要企業をプロファイルしています。

本調査の対象となる主要企業は、Koninklijke DSM NV、KD Pharma Group、The Archer Daniels Midland Company、Corbion NV、Novasep Holding SAS、Neptune Wellness Solutions、BASF SE、Omega Protein Corporation、Croda International PLC、Novotech Nutraceuticals、Herbalife Nutrition Ltd.、Fonterra Co-operative Group Limitedなどがあります。

このレポートから洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。

世界のEPAとDHA市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この産業の様々な利害関係者に対応しています。

利害関係者は、世界のEPAとDHA市場を分析する際に使用される様々な戦略マトリックスを通じて意思決定を容易にすると考えられます。

目次

第1章 調査の目的と前提条件

• 調査目的
• 前提条件
• 略語

第2章 市場展望

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー

第3章 市場力学、規制、動向分析

• 市場力学
• 影響分析
• 規制シナリオ
• 製品の発売/承認
• PEST分析
• ポーター分析
• 市場機会
• 規制シナリオ
• 産業動向

第4章 世界のEPAとDHA市場、供給源別、2020～2032年（10億米ドル）

• イントロダクション
• 魚油
• 藻類油
• オキアミオイル
• その他

第5章 世界のEPAとDHA市場、形態別、2020～2032年（10億米ドル）

• イントロダクション
• 液体
• カプセルとソフトジェル
• 粉末
• その他

第6章 世界のEPAとDHA市場、用途別、2020～2032年（10億米ドル）

• イントロダクション
• 栄養補助食品
• 飲食品
• 医薬品
• その他

第7章 世界のEPAとDHA市場、地域別、2020～2032年（10億米ドル）

• イントロダクション
• 北米
• ラテンアメリカ
• 欧州
• アジア太平洋
• 中東
• アフリカ

第8章 競合情勢

• Koninklijke DSM NV
• KD Pharma Group
• The Archer Daniels Midland Company
• Corbion NV
• Novasep Holding SAS
• Neptune Wellness Solutions
• BASF SE
• Omega Protein Corporation
• Croda International PLC
• Novotech Nutraceuticals
• Herbalife Nutrition Ltd.
• Fonterra Co-operative Group Limited

第9章 アナリストの推奨事項

• 隆盛と衰退
• 一貫型機会マップ

第10章 参考文献と調査手法

• 参考文献
• 調査手法
• 出版社について

Global EPA and DHA Market is estimated to be valued at USD 2.07 Bn in 2025 and is expected to reach USD 3.32 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.0% from 2025 to 2032.

Figure. EPA And DHA Market Share (%), By Region 2025

Global EPA and DHA market has been witnessing significant growth due to rising health consciousness among consumers and growing adoption of supplements containing these key omega-3 fatty acids. EPA and DHA are polyunsaturated fatty acids found in marine sources that play an important role in brain and eye health as well as cardiovascular health. Increasing prevalence of lifestyle diseases along with growing aging population has boosted the demand for EPA and DHA supplements. Various clinical studies have demonstrated the far-ranging benefits of EPA and DHA in reducing inflammation, lowering risk of heart disease, and improving neurological functioning. With growing scientific evidence, more people are incorporating these essential fatty acids into their diets through food sources as well as supplements.

Market Dynamics

Increasing consumer awareness about EPA and DHA health benefits and prevalence of chronic diseases boosts sales of EPA and DHA supplements globally. However, high procurement cost of raw materials poses major challenge for market players. Abundant availability of fish oils as well as emergence of alternative vegan sources of omega-3 fatty acids present lucrative opportunities for the market expansion. Sustained R&D into new applications can expand the clinical uses and market outreach of EPA and DHA.

Key Features of the Study

This report provides in-depth analysis of the global EPA and DHA market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global EPA and DHA market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Koninklijke DSM NV, KD Pharma Group, The Archer Daniels Midland Company, Corbion NV, Novasep Holding SAS, Neptune Wellness Solutions, BASF SE, Omega Protein Corporation, Croda International PLC, Novotech Nutraceuticals, Herbalife Nutrition Ltd., and Fonterra Co-operative Group Limited

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global EPA and DHA market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global EPA and DHA market

Market Segmentation

• By Source Insights (Revenue, USD Bn, 2020 - 2032)
  • Fish Oil
  • Algal Oil
  • Krill Oil
  • Others
• By Form Insights (Revenue, USD Bn, 2020 - 2032)
  • Liquid
  • Capsules and Soft gels
  • Powder
  • Others
• By Application Insights (Revenue, USD Bn, 2020 - 2032)
  • Dietary Supplements
  • Food and Beverages
  • Pharmaceuticals
  • Others
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Koninklijke DSM NV
  • KD Pharma Group
  • The Archer Daniels Midland Company
  • Corbion NV
  • Novasep Holding SAS
  • Neptune Wellness Solutions
  • BASF SE
  • Omega Protein Corporation
  • Croda International PLC
  • Novotech Nutraceuticals
  • Herbalife Nutrition Ltd.
  • Fonterra Co-operative Group Limited

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global EPA and DHA Market, By Source
  • Global EPA and DHA Market, By Form
  • Global EPA and DHA Market, By Application
  • Global EPA and DHA Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Market Opportunities
• Regulatory Scenario
• Key Developments
• Industry Trend

4. Global EPA and DHA Market, By Source, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Fish Oil
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Algal Oil
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Krill Oil
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global EPA and DHA Market, By Form, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Liquid
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Capsules and Soft gels
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Powder
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global EPA and DHA Market, By Application, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Dietary Supplements
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Food and Beverages
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Pharmaceuticals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global EPA and DHA Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032, (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Source, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Form, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Source, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Form, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Source, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Form, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Source, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Form, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Source, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Form, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Source, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Form, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Country/Region, 2020 - 2032, (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

8. Competitive Landscape

• Koninklijke DSM NV
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• KD Pharma Group
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• The Archer Daniels Midland Company
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Corbion NV
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Novasep Holding SAS
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Neptune Wellness Solutions
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• BASF SE
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Omega Protein Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Croda International PLC
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Novotech Nutraceuticals
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Herbalife Nutrition Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Fonterra Co-operative Group Limited
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

9. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About us